REFERENCES
- Kharya G, Yadav SP, Katewa S, Sachdeva A. Management of severe refractory thrombocytopenia in dengue hemorrhagic fever with intravenous anti-D immune globulin. Pediatr Hematol Oncol. 2011 Oct 4. [Epub ahead of print]
- Wiwanitkit V. Dengue fever: diagnosis and treatment. Expert Rev Anti Infect Ther. 2010;8:841–845.
- Wiwanitkit V. Weak binding affinity of immunoglobin G, an explanation for the immune mimicking theory in pathophysiologic findings in the recovery phase of dengue. Nanomedicine. 2005;1:239–240.
- Dimaano EM, Saito M, Honda S, Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection. Am J Trop Med Hyg. 2007;77:1135–1138.
- de Castro RA, de Castro JA, Barez MY, Thrombocytopenia associated with dengue hemorrhagic fever responds to intravenous administration of anti-D (Rh(0)-D) immune globulin. Am J Trop Med Hyg. 2007;76:737–742.
- Yadav SP, Sachdeva A, Gupta D, Control of massive bleeding in dengue hemorrhagic fever with severe thrombocytopenia by use of intravenous anti-D globulin. Pediatr Blood Cancer. 2008;51:812–813.
- Mourão MP, Lacerda MV, Macedo VO, Santos JB. Thrombocytopenia in patients with dengue virus infection in the Brazilian Amazon. Platelets. 2007;18:605–612.
- Alam R, Siddiqui FM, Rahman S, Management of dengue by the WHO guided national guidelines. Mymensingh Med J. 2004;13:43–47.